{{Rsnum
|rsid=17021918
|Gene=PDLIM5
|Chromosome=4
|position=94641726
|Orientation=plus
|GMAF=0.3108
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PDLIM5
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.2 | 40.7 | 15.0
| HCB | 40.4 | 50.0 | 9.6
| JPT | 37.2 | 48.7 | 14.2
| YRI | 65.3 | 29.9 | 4.8
| ASW | 54.4 | 38.6 | 7.0
| CHB | 40.4 | 50.0 | 9.6
| CHD | 47.7 | 43.9 | 8.4
| GIH | 64.4 | 31.7 | 4.0
| LWK | 58.7 | 35.8 | 5.5
| MEX | 53.4 | 43.1 | 3.4
| MKK | 45.2 | 42.6 | 12.3
| TSI | 43.1 | 46.1 | 10.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19767753
|Trait=Prostate cancer
|Title=Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
|RiskAllele=T
|Pval=4E-15
|OR=1.11
|ORtxt=[1.08-1.15]
|OA=1
}}

{{PMID Auto
|PMID=21390317
|Title=Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17021918
|overall_frequency_n=32
|overall_frequency_d=124
|overall_frequency=0.258065
|n_genomes=21
|n_genomes_annotated=0
|n_haplomes=24
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23573233
|Title=Characterization of SNPs Associated with Prostate Cancer in Men of Ashkenazic Descent from the Set of GWAS Identified SNPs: Impact of Cancer Family History and Cumulative SNP Risk Prediction
|OA=1
}}

{{PMID Auto
|PMID=24411283
|Title=Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}